Book contents
- Core Topics in Cardiothoracic Critical Care
- Core Topics in Cardiothoracic Critical Care
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to the Second Edition
- Link between Cardiothoracic Anaesthesia and Intensive Care: Which Patients are Admitted to Critical Care?
- Scoring Systems and Prognosis
- Abbreviations
- Section 1 Diagnosis
- Section 2 Practical Procedures
- Section 3 Therapeutic Intervention
- 12 Antibiotics in the Cardiothoracic Intensive Care Unit
- 13 Blood Products and Transfusion
- 14 Fluid Administration
- 15 Inotropes and Vasopressors
- 16 Sedation and Analgesia
- 17 Mechanical Ventilation
- 18 Renal Replacement Therapy
- 19 Nutritional Support for Cardiac Surgery and Intensive Care
- 20 Physiotherapy and Rehabilitation
- Section 4 Advanced Organ Support
- Section 5 Acute Disorders
- Section 6 Perioperative Care: The Patient Post Cardiac Surgery
- Section 7 Disease Management in the Cardiothoracic Intensive Care Unit: Incidence; Aetiology; Diagnosis; Prognosis; Treatment
- Section 8 Provision and Delivery of Cardiothoracic Intensive Care
- Exercise Answers
- Index
- References
15 - Inotropes and Vasopressors
from Section 3 - Therapeutic Intervention
Published online by Cambridge University Press: 15 June 2018
Book contents
- Core Topics in Cardiothoracic Critical Care
- Core Topics in Cardiothoracic Critical Care
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to the Second Edition
- Link between Cardiothoracic Anaesthesia and Intensive Care: Which Patients are Admitted to Critical Care?
- Scoring Systems and Prognosis
- Abbreviations
- Section 1 Diagnosis
- Section 2 Practical Procedures
- Section 3 Therapeutic Intervention
- 12 Antibiotics in the Cardiothoracic Intensive Care Unit
- 13 Blood Products and Transfusion
- 14 Fluid Administration
- 15 Inotropes and Vasopressors
- 16 Sedation and Analgesia
- 17 Mechanical Ventilation
- 18 Renal Replacement Therapy
- 19 Nutritional Support for Cardiac Surgery and Intensive Care
- 20 Physiotherapy and Rehabilitation
- Section 4 Advanced Organ Support
- Section 5 Acute Disorders
- Section 6 Perioperative Care: The Patient Post Cardiac Surgery
- Section 7 Disease Management in the Cardiothoracic Intensive Care Unit: Incidence; Aetiology; Diagnosis; Prognosis; Treatment
- Section 8 Provision and Delivery of Cardiothoracic Intensive Care
- Exercise Answers
- Index
- References
- Type
- Chapter
- Information
- Core Topics in Cardiothoracic Critical Care , pp. 123 - 129Publisher: Cambridge University PressPrint publication year: 2018
References
Further Reading
Alhashemi, JA. Treatment of cardiogenic shock with levosimendan in combination with β-adrenergic antagonists. British Journal of Anaesthesia. 2005; 95: 648–650. doi: 10.1093/bja/aei225CrossRefGoogle ScholarPubMed
Bellomo, R, Chapman, M, Finfer, S, Hickling, K, Myburgh, J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000; 356: 2139–2143.Google ScholarPubMed
De Backer, D, Biston, P, Devriendt, J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. New England Journal of Medicine. 2010; 362: 779–789.CrossRefGoogle ScholarPubMed
Klein, L, Massie, BM, Leimberger, JD, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circulation: Heart Failure. 2008; 1: 25–33.Google ScholarPubMed
Laflamme, M, Perrault, LP, Carrier, M, et al. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension. Journal of Cardiothoracic and Vascular Anesthesia. 2015; 29: 38–45.CrossRefGoogle ScholarPubMed
Levy, B, Perez, P, Perny, J, Thivilier, C, Gerard, A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Critical Care Medicine. 2011; 39: 450–455.CrossRefGoogle ScholarPubMed
Majure, DT, Greco, T, Greco, M, et al. Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery: an update. Journal of Cardiothoracic and Vascular Anesthesia. 2013; 27: 220–229.CrossRefGoogle ScholarPubMed
Mebazaa, A, Nieminen, MS, Packer, M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. Journal of the American Medical Association. 2007; 297: 1883–1891.CrossRefGoogle ScholarPubMed
Movsesian, M, Stehlik, J, Vandeput, F, Bristow, MR. Phosphodiesterase inhibition in heart failure. Heart Failure Reviews. 2009; 14: 255–263.CrossRefGoogle ScholarPubMed
Nathan Coxford, R, Lang, E, Dowling, S. Dopamine versus norepinephrine in the treatment of shock. Canadian Journal of Emergency Medicine. 2011; 13: 395–397.Google ScholarPubMed
Ozal, E, Kuralay, E, Yildirim, V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Annals of Thoracic Surgery. 2005; 79: 1615–1619.CrossRefGoogle ScholarPubMed